Sign inGet started

Ende Eric J

Insider CIK 1494386 · AVDL Director · NBSE Director · MTNB Director · PGNX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1211,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1211,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1233,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1242,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1242,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1242,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-1260,000— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-128,057— $00SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer2026-02-122026-02-12219,905$21.00 $4.62M0SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2025-07-292025-07-3111,000— $011,000SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award2025-07-292025-07-3111,000— $0219,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2025-01-132025-01-1430,000$7.84 $235.2K208,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2024-07-302024-08-0111,000— $011,000SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award2024-07-302024-08-0111,000— $0178,900SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2023-11-012023-11-03437,244— $0437,244SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2023-08-012023-08-0333,000— $033,000SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2023-05-182023-05-1913,000$13.93 $181.1K167,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2022-11-222022-11-2320,000$7.80 $156.0K154,900SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2022-11-142022-11-16142,657— $0142,657SEC↗
NBSE NeuBase Therapeutics, Inc. A Award deriv2022-09-092022-09-1237,600— $037,600SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2022-08-032022-08-0542,000— $042,000SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2022-06-012022-06-0120,000$2.27 $45.4K134,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2022-05-312022-06-0115,000$2.16 $32.4K114,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2022-05-272022-05-3115,000$2.45 $36.8K99,900SEC↗
NBSE NeuBase Therapeutics, Inc. A Award deriv2022-01-012022-01-05165,803— $0165,803SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2021-11-012021-11-0290,882— $090,882SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2021-08-032021-08-0542,000— $042,000SEC↗
MTNB Matinas BioPharma Holdings C Conversion deriv2021-06-192021-06-2412— $00SEC↗
MTNB Matinas BioPharma Holdings C Conversion2021-06-192021-06-2424,000— $0144,092SEC↗
MTNB Matinas BioPharma Holdings J Other2021-06-192021-06-244,800— $0120,092SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2020-11-022020-11-10122,605— $0122,605SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2020-09-172020-09-1817,000$5.79 $98.4K84,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2020-08-132020-08-173,800$7.80 $29.6K67,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2020-08-132020-08-171,200$7.74 $9.3K64,100SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2020-08-122020-08-1315,000$7.76 $116.4K62,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2020-08-072020-08-1142,000— $042,000SEC↗
MTNB Matinas BioPharma Holdings J Other2020-06-232020-06-243,600— $0115,292SEC↗
PGNX PROGENICS PHARMACEUTICALS D To issuer deriv2020-06-192020-06-2340,000— $00SEC↗
PGNX PROGENICS PHARMACEUTICALS D To issuer deriv2020-06-192020-06-2316,393— $00SEC↗
PGNX PROGENICS PHARMACEUTICALS A Award deriv2019-12-132019-12-1740,000— $040,000SEC↗
PGNX PROGENICS PHARMACEUTICALS A Award deriv2019-12-132019-12-1716,393— $016,393SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2019-12-042019-12-0510,000$5.97 $59.7K47,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC P Buy2019-11-152019-11-1910,000$4.98 $49.8K37,900SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2019-11-012019-11-05107,416— $0107,416SEC↗
MTNB Matinas BioPharma Holdings P Buy2019-08-202019-08-2220,000$0.66 $13.2K109,292SEC↗
MTNB Matinas BioPharma Holdings P Buy2019-08-192019-08-2120,000$0.68 $13.6K89,292SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2019-08-072019-08-0960,000— $060,000SEC↗
MTNB Matinas BioPharma Holdings J Other2019-06-212019-11-052,400— $0111,692SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2019-05-222019-05-248,057— $08,057SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award2019-01-312019-05-2427,900— $027,900SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award2019-01-312019-02-0427,900— $027,900SEC↗
MTNB Matinas BioPharma Holdings A Award2018-12-312019-01-0415,022— $057,091SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2018-11-012018-11-05128,299— $0128,299SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2018-11-012018-11-05128,299— $0128,299SEC↗
MTNB Matinas BioPharma Holdings A Award2018-10-012018-10-039,715— $042,069SEC↗
MTNB Matinas BioPharma Holdings A Award2018-06-292018-07-1120,594— $032,354SEC↗
MTNB Matinas BioPharma Holdings P Buy deriv2018-06-212018-06-2212$1000.00 $12.0K12SEC↗
MTNB Matinas BioPharma Holdings A Award2018-03-302018-04-0211,760— $011,760SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2017-12-142018-02-27250,000— $0250,000SEC↗
MTNB Matinas BioPharma Holdings A Award2017-04-032019-04-0312,201— $012,201SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2017-04-032017-07-19150,000$2.92 $438.0K150,000SEC↗
MTNB Matinas BioPharma Holdings A Award deriv2017-04-032017-04-21150,000$2.92 $438.0K150,000SEC↗